Meeting
2021 ASCO Annual Meeting
The genomic landscape of gene fusions across solid tumors and clinical outcome of targeted therapies: A real-world retrospective analysis.
Authors
Yumeng Zhang
Hematology/Oncology Fellowship, Moffitt Cancer Center, Tampa, FL
Yumeng Zhang , Bindiya G Patel , Todd C Knepper , Dung-Tsa Chen , Jhanelle Elaine Gray , James Kevin Hicks
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Other Developmental Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3132)
DOI
10.1200/JCO.2021.39.15_suppl.3132
Abstract #
3132
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US).
First Author: Ruchit Shah
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang
Poster
2022 ASCO Annual Meeting
Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.
First Author: Zhouhuan Dong
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya